Ignacio Martín-Loeches-rekin lankidetzan egindako argitalpenak (28)

2024

  1. Association of obesity on the outcome of critically ill patients affected by COVID-19

    Medicina Intensiva, Vol. 48, Núm. 3, pp. 142-154

2023

  1. A differential therapeutic consideration for use of corticosteroids according to established COVID-19 clinical phenotypes in critically ill patients

    Medicina Intensiva, Vol. 47, Núm. 1, pp. 23-33

  2. Correction: Microbiological diagnosis of pulmonary invasive aspergillosis in critically ill patients with severe SARS-CoV-2 pneumonia: a bronchoalveolar study (Annals of Clinical Microbiology and Antimicrobials, (2023), 22, 1, (90), 10.1186/s12941-023-00626-7)

    Annals of Clinical Microbiology and Antimicrobials

  3. Risk factors for developing ventilator-associated lower respiratory tract infection in patients with severe COVID-19: a multinational, multicentre study, prospective, observational study

    Scientific reports, Vol. 13, Núm. 1, pp. 6553

2022

  1. Dexamethasone as risk-factor for ICU-acquired respiratory tract infections in severe COVID-19

    Journal of Critical Care, Vol. 69

  2. Negative predictive value of procalcitonin to rule out bacterial respiratory co-infection in critical covid-19 patients

    Journal of Infection, Vol. 85, Núm. 4, pp. 374-381

  3. Prior influenza vaccine is not a risk factor for bacterial coinfection in patients admitted to the ICU due to severe influenza

    Medicina Intensiva, Vol. 46, Núm. 8, pp. 436-445

  4. Recommendations for the management of critically ill patients with COVID-19 in Intensive Care Units

    Medicina Intensiva, Vol. 46, Núm. 2, pp. 81-89

2021

  1. Corticosteroid treatment and mortality in mechanically ventilated COVID-19-associated acute respiratory distress syndrome (ARDS) patients: a multicentre cohort study

    Annals of Intensive Care, Vol. 11, Núm. 1

  2. Deploying unsupervised clustering analysis to derive clinical phenotypes and risk factors associated with mortality risk in 2022 critically ill patients with COVID-19 in Spain

    Critical Care, Vol. 25, Núm. 1

  3. Management of infectious complications associated with coronavirus infection in severe patients admitted to ICU

    Medicina Intensiva, Vol. 45, Núm. 8, pp. 485-500

  4. Mortality comparison between the first and second/third waves among 3,795 critical COVID-19 patients with pneumonia admitted to the ICU: A multicentre retrospective cohort study

    The Lancet Regional Health - Europe, Vol. 11

  5. Prognostic value of procalcitonin and c-reactive protein in 1608 critically ill patients with severe influenza pneumonia

    Antibiotics, Vol. 10, Núm. 4

2020

  1. Antimicrobial de-escalation in the critically ill patient and assessment of clinical cure: the DIANA study

    Intensive Care Medicine, Vol. 46, Núm. 7, pp. 1404-1417

  2. The clinical relevance of oliguria in the critically ill patient: Analysis of a large observational database

    Critical Care, Vol. 24, Núm. 1

2019

  1. The association of cardiovascular failure with treatment for ventilator-associated lower respiratory tract infection

    Intensive Care Medicine, Vol. 45, Núm. 12, pp. 1753-1762

2018

  1. Comparison of European ICU patients in 2012 (ICON) versus 2002 (SOAP)

    Intensive Care Medicine, Vol. 44, Núm. 3, pp. 337-344

  2. Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study

    Intensive Care Medicine, Vol. 44, Núm. 9, pp. 1470-1482

2017

  1. Decision-Making on Withholding or Withdrawing Life Support in the ICU: A Worldwide Perspective

    Chest, Vol. 152, Núm. 2, pp. 321-329

2016

  1. Delay in diagnosis of influenza A (H1N1)pdm09 virus infection in critically ill patients and impact on clinical outcome

    Critical Care, Vol. 20, Núm. 1